Best on the Street

Genius Group Appoints Leading Edtech Investor Michael Moe as Board Chairman

Retrieved on: 
Friday, April 19, 2024
Science, AIR, University, Learning, Genius, National Football Foundation, The Wall Street Journal, Arizona State University, AI, Davos, Research, ThinkEquity, Merrill (company), Computer, NXT TakeOver, Mission, Education reform, GSV, ClassDojo, Book, Air show, Guild Education, CFA, Chartered, Next, Economics, Course Hero, Best on the Street, Management

SINGAPORE, April 19, 2024 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered education group, today announced the appointment of Mr. Michael Moe as Non Executive Chairman of its Board.

Key Points: 
  • SINGAPORE, April 19, 2024 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered education group, today announced the appointment of Mr. Michael Moe as Non Executive Chairman of its Board.
  • He has been appointed in this role following the Genius Group’s recently announced business combination with FatBrain AI, where Mr Moe is also a shareholder and Chairman.
  • Michael Moe is the Founder and CEO of GSV Holdings.
  • Michael is an exceptional addition to Genius Group, and we are very fortunate to have him join us both as a shareholder and as the new Chairman of our Board.”

iLearningEngines, Inc. to Add Michael Moe and Sir Ian Davis to its Board of Directors

Retrieved on: 
Thursday, March 28, 2024
Technology, Software, Networks, Other Education, Training, University, Primary, Secondary, Data Management, Education, Research, The Wall Street Journal, McKinsey & Company, ThinkEquity, Next, GSV, Best on the Street, Worldwide, Growth, BP, Rolls-Royce Holdings, Course Hero, Merrill (company), Meta, Guild Education, Business analyst, Senior, Spotify, Investment, Mission, Book, Big Society Capital, Management

Michael Moe and Ian Davis, who have more than 60 years of business, investment and technology experience, will join Harish Chidambaran, Balakrishnan Arackal, Tom Olivier, Matthew Barger and Bruce Mehlman on the board of New iLearningEngines following the Business Combination.

Key Points: 
  • Michael Moe and Ian Davis, who have more than 60 years of business, investment and technology experience, will join Harish Chidambaran, Balakrishnan Arackal, Tom Olivier, Matthew Barger and Bruce Mehlman on the board of New iLearningEngines following the Business Combination.
  • Mr. Moe is the Founder and CEO of GSV, a growth-focused investment platform.
  • “We are honored to welcome Michael and Ian to the New iLearningEngines Board,” said Harish Chidambaran, CEO of iLearningEngines.
  • I look forward to contributing to their continued success as a publicly traded company.”
    For more information about iLearningEngines, please visit: www.ilearningengines.com .

NEXGEL Appoints Scott Henry, CFA to Board of Directors and Audit Committee

Retrieved on: 
Tuesday, January 17, 2023
Roth Capital Partners, ABN, University, The Wall Street Journal, CFA, Biotechnology, Knowledge, Best on the Street, Growth, The New York Times, Cornell University, Audit committee, Dow Jones & Company, MarketWatch, ABN AMRO, Bloomberg, CNBC, CBS, Management

Mr. Henry will also serve as a member of the Board's Audit Committee.

Key Points: 
  • Mr. Henry will also serve as a member of the Board's Audit Committee.
  • "Scott brings a wealth of financial and operational experience to NEXGEL, making him an ideal addition to our Board and Audit Committee," said Adam Levy, Chief Executive Officer of NEXGEL.
  • Scott R. Henry, CFA, is a Managing Director, Senior Research Analyst at ROTH Capital Partners with 20 years of sell-side coverage in the pharmaceutical, biotechnology and medical device sectors.
  • Mr. Henry commented, "After spending extensive time with Adam and the rest of the senior leadership team, I was excited to join the NEXGEL team as a member of the Board and Audit Committee.

Ceruvia Lifesciences Appoints Stephen Hurst and David Steinberg to its Board of Directors

Retrieved on: 
Wednesday, November 2, 2022
Board of directors, The Wall Street Journal, CEO, Sequence, Hurst, Savant syndrome, Steinberg, OCD, World, Global Health, Research, Board, Deutsche Bank, Director, Industry, Harvard Medical School, New York University Grossman School of Medicine, Speech disorder, World Bank, CFO, Best on the Street, Yale School of Medicine, Wall Street, Therapy, Initial public offering, Jefferies, Patient, Jefferies Group, Biotechnology, Institution, Pharmaceutical industry, Management, Medicine

GREENWICH, Conn., Nov. 2, 2022 /PRNewswire/ --Ceruvia Lifesciences, a leading neurotransformational biopharmaceutical company, is pleased to announce the appointment of Stephen Hurst and David Steinberg to its Board of Directors, effective immediately.

Key Points: 
  • GREENWICH, Conn., Nov. 2, 2022 /PRNewswire/ --Ceruvia Lifesciences, a leading neurotransformational biopharmaceutical company, is pleased to announce the appointment of Stephen Hurst and David Steinberg to its Board of Directors, effective immediately.
  • "We are thrilled to welcome Steve to Ceruvia's Board of Directors," said Carey Turnbull, Founder and CEO of Ceruvia Lifesciences.
  • Stephen Hurst said, "I am honored to be joining the Board of Ceruvia Lifesciences.
  • "We are pleased to welcome David to Ceruvia's Board of Directors," said Carey Turnbull, Founder and CEO of Ceruvia Lifesciences.

Ceruvia Lifesciences Appoints Stephen Hurst and David Steinberg to its Board of Directors

Retrieved on: 
Wednesday, November 2, 2022
Board of directors, The Wall Street Journal, CEO, Sequence, Hurst, Savant syndrome, Steinberg, OCD, World, Global Health, Research, Board, Deutsche Bank, Director, Industry, Harvard Medical School, New York University Grossman School of Medicine, Speech disorder, World Bank, CFO, Best on the Street, Yale School of Medicine, Wall Street, Therapy, Initial public offering, Jefferies, Patient, Jefferies Group, Biotechnology, Institution, Pharmaceutical industry, Management, Medicine

GREENWICH, Conn., Nov. 2, 2022 /PRNewswire/ --Ceruvia Lifesciences, a leading neurotransformational biopharmaceutical company, is pleased to announce the appointment of Stephen Hurst and David Steinberg to its Board of Directors, effective immediately.

Key Points: 
  • GREENWICH, Conn., Nov. 2, 2022 /PRNewswire/ --Ceruvia Lifesciences, a leading neurotransformational biopharmaceutical company, is pleased to announce the appointment of Stephen Hurst and David Steinberg to its Board of Directors, effective immediately.
  • "We are thrilled to welcome Steve to Ceruvia's Board of Directors," said Carey Turnbull, Founder and CEO of Ceruvia Lifesciences.
  • Stephen Hurst said, "I am honored to be joining the Board of Ceruvia Lifesciences.
  • "We are pleased to welcome David to Ceruvia's Board of Directors," said Carey Turnbull, Founder and CEO of Ceruvia Lifesciences.